5-hydroxy-2-(4-hydroxyphenyl)-4-oxochroman-7-yl piperidine-1-carboxylate

ID: ALA4872071

PubChem CID: 164624318

Max Phase: Preclinical

Molecular Formula: C21H21NO6

Molecular Weight: 383.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1CC(c2ccc(O)cc2)Oc2cc(OC(=O)N3CCCCC3)cc(O)c21

Standard InChI:  InChI=1S/C21H21NO6/c23-14-6-4-13(5-7-14)18-12-17(25)20-16(24)10-15(11-19(20)28-18)27-21(26)22-8-2-1-3-9-22/h4-7,10-11,18,23-24H,1-3,8-9,12H2

Standard InChI Key:  JJBJGWQQJZMGGD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    4.4560   -5.1095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4548   -5.9290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1629   -6.3380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8726   -5.9285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8697   -5.1059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1611   -4.7006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7468   -6.3370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5759   -4.6946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2825   -5.1028    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2786   -3.4694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5683   -3.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9877   -3.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9836   -4.6950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6885   -5.1054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3978   -4.6995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3979   -3.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6925   -3.4721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2783   -2.6522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6929   -2.6549    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1047   -5.1095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8132   -4.7023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5201   -5.1123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8148   -3.8851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5154   -5.9319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2183   -6.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9292   -5.9381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9327   -5.1199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2254   -4.7055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  5  8  1  0
  8  9  1  0
  8 11  1  0
  9 13  1  0
 12 10  1  0
 10 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 18  2  0
 17 19  1  0
 15 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 22 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872071

    ---

Associated Targets(Human)

APP Tclin Amyloid-beta A4 protein (8510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.40Molecular Weight (Monoisotopic): 383.1369AlogP: 3.79#Rotatable Bonds: 2
Polar Surface Area: 96.30Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.20CX Basic pKa: CX LogP: 3.71CX LogD: 3.65
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.82Np Likeness Score: 0.73

References

1. Wu J, Kou X, Ju H, Zhang H, Yang A, Shen R..  (2021)  Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.,  49  [PMID:34391893] [10.1016/j.bmcl.2021.128316]

Source